• Overview
    • Goals & Strategy
    • Executive Management
    • Board of Directors
    • Scientific Advisory Board
    • Business Development
    • Intellectual Property
  • Product Pipeline
    • Cancer
    • Infectious Disease
    • Inflammatory Disease
  • Programs and Technologies
    • APC Targeting Technology™
    • Therapeutic Antibody Program
    • Immune System Modulators
  • Clinical Trials
    • Cancer Current Trials
    • Infectious Diseases Current Trials
  • Investors
    • Investor Overview
    • Stock Quote
    • Financial Reports
    • Corporate Governance
    • Presentations
    • Information Requests
  • News & Events
    • Events Calendar
    • Scientific Articles
    • Media Kit
  • Careers
    • A Great Place to Work
    • Benefits
    • Current Opportunities
  • Investor Overview
  • Stock Quote
  • Financial Reports
  • Corporate Governance
  • Presentations
  • Information Requests

Investor Tool Kit

E-mail Page E-mail Page
RSS Feeds RSS Feeds
E-mail Alerts E-mail Alerts
IR Contacts IR Contacts
Financial Tear Sheet Financial Tear Sheet

Presentations

Receive E-mail AlertsE-mail Alerts
DateTitleDurationFormat/Plug-in Support
11/05/08
Q3 2008 Celldex Therapeutics, Inc. Earnings Conference Call
27 minutesDownload Documentation
09/23/08
AVANT Immunotherapeutics, Inc. at UBS Global Life Sciences Conference
30 minutesDownload Documentation
08/06/08
Q2 2008 AVANT Immunotherapeutics, Inc. Earnings Conference Call
22 minutesDownload Documentation
05/20/08
Q1 2008 AVANT Immunotherapeutics, Inc. Earnings Conference Call
20 minutesDownload Documentation
02/27/08
Q4 2007 AVANT Immunotherapeutics, Inc. Earnings Conference Call
16 minutesDownload Documentation
No duty to update.

Printer Friendly Version 

©2008 Celldex, Inc | Legal Information | Privacy Policy
ContactSite Map
Search